Opus Genetics, Inc. Treasury Stock, Value
Opus Genetics, Inc. (IRD) had Treasury Stock, Value of $128.41 thousand as of 2015-09-30, per its 10-Q filed 2015-11-02.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2016-03-14
- 2015-09-30: Treasury Stock, Value $128.41K.
- 2015-06-30: Treasury Stock, Value $128.41K.
- 2015-03-31: Treasury Stock, Value $128.41K.
- 2014-12-31: Treasury Stock, Value $128.41K.
| Period end | Treasury Stock, Value |
|---|---|
| 2015-09-30 | $128.41K 10-Q · filed 2015-11-02 |
| 2015-06-30 | $128.41K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $128.41K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $128.41K 10-K · filed 2016-03-14 |
| 2014-09-30 | $128.41K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $128.41K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $28.41K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $28.41K 10-K · filed 2015-03-16 |
| 2013-09-30 | $28.41K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $28.41K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $28.41K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $28.41K 10-K · filed 2014-03-21 |
| 2012-09-30 | $28.41K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $28.41K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $28.41K 10-Q · filed 2012-05-09 |
| 2011-12-31 | $28.41K 10-K · filed 2013-03-22 |
| 2011-09-30 | $28.41K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $28.41K 10-Q · filed 2011-08-09 |
| 2010-12-31 | $28.41K 10-K · filed 2012-03-16 |
| 2006-04-12 | $28.41K 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |